On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
The speaker will highlight the urgent and growing global threat posed by antimicrobial resistance (AMR) in tuberculosis (TB) and other non-tuberculous mycobacterial (NTM) infections. This talk will address the major challenges in developing new therapeutic strategies to target the varied physiological states of these resilient pathogens and their exceptional ability to evade host defence mechanisms across human, animal, and environmental settings, within biofilm-forming microbiomes. Drawing on recent research findings, the seminar will discuss the validation of novel therapeutic targets that could accelerate drug design and discovery efforts. In particular, it will highlight promising work on the repurposing of carprofen, a non-steroidal anti-inflammatory drug, to help reverse drug resistance in TB and NTM diseases.
This interdisciplinary seminar is designed to engage a broad audience, including researchers in basic science, public health professionals, clinicians, and industry experts, all united by a shared interest in tackling one of the most pressing health threats of our time.
